Randall K. Wolf Named Ethicon Endo-Surgery Chair
Randall K. Wolf, MD, an internationally recognized pioneer in minimally invasive and robotic surgery, has been named to the newly established Ethicon Endo-Surgery Chair in the Department of Surgery at the UC College of Medicine.
Ethicon Endo-Surgery Inc. contributed funding to support the chair and UCs new Center for
Surgical Innovation (CSI).
With this new chair, Dr. Wolf is leading UC into discovery that directly translates into better care for patients, said Jeffrey Matthews, MD, Christian R. Holmes Professor and chair of UCs Department of Surgery.
Dr. Wolf, director of the CSI and professor of both surgery and biomedical engineering, was the first surgeon in the United States to use the da Vinci robotic surgical system for minimally invasive heart surgery.
He headed Ethicon Endo-Surgerys first training courses in minimally invasive thoracic surgery and has collaborated with the Blue Ash, Ohio, company on several new technologies.
Dr. Wolf also led the research team that developed the Wolf Mini Maze, a minimally invasive surgical procedure that cures an irregular heartbeat condition called atrial fibrillation, utilizing an endoscopic technique. Atrial fibrillation increases the risk of heart attack or stroke and affects 2.5 million Americans.
A native Cincinnatian, Dr. Wolf has performed minimally invasive heart surgery in more than 15 countries and trains cardiac surgeons from around the world in minimally invasive techniques.
He is the current president of the International Society of Minimally Invasive Cardiothoracic Society and president-elect of the 21st Century Cardiac Surgery Club.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.